Abbott Denied Summary Judgment in Humira Injury Case



DOCUMENTS
  • Order


MEMPHIS, Tenn. — A Tennessee federal judge has denied Abbott Laboratories Inc.’s (NYSE: ABT) motion for summary judgment in a Humira failure-to-warn case, ruling that the plaintiffs provided sufficient evidence that the drug maker agreed to toll the state’s statute of limitations on product liability claims.

On Dec. 6, Judge William G. Young of the U.S. District Court for the Western District of Tennessee found that an email proffered by plaintiffs is consistent with their position that Abbott had previously waived the statute of limitations defense for a specific time frame in an informal tolling agreement.

According to the June …

FIRM NAMES
  • Baker Donelson Bearman Caldwell & Berkowitz
  • Kirkland & Ellis
  • Law Office of Eddie Schmidt
  • Perdue Kidd & Vickery





UPCOMING CONFERENCES




HarrisMartin's MDL Conference: Managing Mass Torts, Status of Key Litigations and Lessons Learned

March 29, 2023 - Tucson, AZ
Omni Tucson National Resort

MORE DETAILS



HarrisMartin's New Jersey Asbestos Litigation Conference

March 03, 2023 - New Brunswick, NJ
Hyatt Regency New Brunswick

MORE DETAILS